Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Treatment Induced Thrombocytopenia”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableStudy completedNCT05688306
What this trial is testing

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Liaoning Cancer Hospital & Institute 3,494
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Large-scale testing (Phase 3)Study completedNCT03976882
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 129
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Post-approval studies (Phase 4)Looking for participantsNCT05411705
What this trial is testing

Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury

Who this might be right for
Cancer Treatment Induced Thrombocytopenia
The First Affiliated Hospital of Dalian Medical University 165
Testing effectiveness (Phase 2)Looking for participantsNCT06433830
What this trial is testing

Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

Who this might be right for
ThrombocytopeniaRadiotherapy Side Effect
Sir Run Run Shaw Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00283439
What this trial is testing

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Who this might be right for
Chemotherapy-Induced ThrombocytopeniaHodgkin's LymphomaNon-Hodgkin's Lymphoma+3 more
Amgen 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07334093
What this trial is testing

Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Who this might be right for
Cancer Therapy-induced Thrombocytopenia (CTIT)
Sun Yat-sen University 204
Early research (Phase 1)Looking for participantsNCT07110090
What this trial is testing

Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Who this might be right for
ThrombocytopeniaCancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 16
Testing effectiveness (Phase 2)Study completedNCT00002665
What this trial is testing

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaNeutropeniaThrombocytopenia
SWOG Cancer Research Network 50
Large-scale testing (Phase 3)Study completedNCT03471078
What this trial is testing

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sobi, Inc. 122
Large-scale testing (Phase 3)Study completedNCT03362177
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 165
Testing effectiveness (Phase 2)Study completedNCT00413283
What this trial is testing

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more
Amgen 63
Testing effectiveness (Phase 2)UnknownNCT04896528
What this trial is testing

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Who this might be right for
ThrombocytopeniaAvatrombopag
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07257809
What this trial is testing

Herombopag Treated T-DM1 Induced Platelet Reduction

Who this might be right for
Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 56
Not applicableStudy completedNCT04609891
What this trial is testing

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Who this might be right for
Thrombocytopenia
Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05864014
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 213
Large-scale testing (Phase 3)Not Yet RecruitingNCT06759636
What this trial is testing

FRIENDS-01：A Multicenter Open-label Randomized Controlled Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Who this might be right for
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University 88
Not applicableUnknownNCT03049774
What this trial is testing

The Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Angde Biotech Pharmaceutical Co., Ltd. 2,000
Load More Results